Personal Information
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.marcusevans.com
Info
For more information contact: moreinfo@marcusevanscy.com. The marcus evans Pharma Division delivers high level business events for the pharmaceuticals community. Our Summits are designed to meet the networking, knowledge and business requirements of executives working for the pharmaceuticals, biotechnology, drug discovery and development fields.
Tags
evolution summit
marcus evans
clinical trials
drug development
drug discovery
pharma
drug trials
pharmaceutical marketing
pharmaceutical
pharma evolution
alexander fetkovsky
pharmamarketing summit
clinical development
discovery summit
evolution
life sciences
drug evolution
sanaclis
inc.
evolution summits
marketing
veristat
pharmaceuticals
deepen patel
topstone research
sonia sethi
kenneth kaitin
interview
clinical research
janssen pharmaceuticals
erwin de beuckelaer
clinical trial operations
clinical trial supply chain
kristine koontz
jim fratantonio
alkermes
tom mccourt
ironwood pharmaceutical
telemedicine
biopharma
biotech
court square group inc.
keith parent
decentralized trials
icon plc
hybrid trials
eb mclindon
patient enrollment
dyania health
eirini schlosser
roman hrynchuk
clinical trial patient recruitment
ind application fda
kevin hennegan
kathleen boruchowski
medical monitors
fox chase cancer center
ipsen
risk based monitoring
lori tierney
allergan
ascendis pharma
dunya botetzayas
risk-based monitoring
clinical studies
chief marketing officer
cmo
pharma industry
clinical study feasibility process
clinical study
evolution asia
abbvie
pharma r&d
big-data opportunities
kyle holen
clinical trials in europe
cros
clinical study metrics
clinical trial data management
mark wingertzahn
glaxosmithcline
patient centricity
evolution europe
steven fruchtman
onconova therapeutics
patient records
chitra lele
drug safety
clinical study health
patient emrollment
graeme ladds
drug safety data
pharsafer
topstone research inc
clicnical trials
pharma discovery
kelley kendle
synchrogenix
evolution summit 2015
idiopathic pulmonary fibrosis
boehringer ingelheim pharmaceuticals
andreas grauer
amgen
tufts center
eisai pharmceuticals
johan luthman
gary romano
johnson and johnson
visiopharm
image analysis
drug development challenges
tufts
clinart mena
alaa assem
business development activities interview - clinar
lundbeck
interactive corporation
drugdev
sanaclis s.r.o.
conducting clinical trials in emerging markets wit
marcus evans evolution summit 2015
clinical trial efficiency should be a key focus
suvro ghosh
clinzen llc
acurian
roger smith
why quantitative comparison of patient recruitment
staffan gestrelius
capish
where marcus evans fits in our business developmen
syndax
hematology
oncology drug development
biomarkers
clinical trial standardization
primorus clinical trials
localization
biorasi
multitouch marketing
pharmaceutical development
hispanic patients
maximizing procedure
site identification
patient recruitment & retention
biomedical research
pharmabrand summit
medication administration
long-term care cxo summit
patient recruitment
forest research institute
ind
global regulatory strategy
new drug development
cta
translational medicine
non-porfits medical research foundation
disease treatment
modeling and simulation technologies
in silco to in vivo
optimized drug development
drug discovery summit
pharma marketing
chief marketing officers
cmos
pharmabrand
bayer pharmaceuticals
summit
Mehr anzeigen
Präsentationen
(29)Dokumente
(13)Personal Information
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.marcusevans.com
Info
For more information contact: moreinfo@marcusevanscy.com. The marcus evans Pharma Division delivers high level business events for the pharmaceuticals community. Our Summits are designed to meet the networking, knowledge and business requirements of executives working for the pharmaceuticals, biotechnology, drug discovery and development fields.
Tags
evolution summit
marcus evans
clinical trials
drug development
drug discovery
pharma
drug trials
pharmaceutical marketing
pharmaceutical
pharma evolution
alexander fetkovsky
pharmamarketing summit
clinical development
discovery summit
evolution
life sciences
drug evolution
sanaclis
inc.
evolution summits
marketing
veristat
pharmaceuticals
deepen patel
topstone research
sonia sethi
kenneth kaitin
interview
clinical research
janssen pharmaceuticals
erwin de beuckelaer
clinical trial operations
clinical trial supply chain
kristine koontz
jim fratantonio
alkermes
tom mccourt
ironwood pharmaceutical
telemedicine
biopharma
biotech
court square group inc.
keith parent
decentralized trials
icon plc
hybrid trials
eb mclindon
patient enrollment
dyania health
eirini schlosser
roman hrynchuk
clinical trial patient recruitment
ind application fda
kevin hennegan
kathleen boruchowski
medical monitors
fox chase cancer center
ipsen
risk based monitoring
lori tierney
allergan
ascendis pharma
dunya botetzayas
risk-based monitoring
clinical studies
chief marketing officer
cmo
pharma industry
clinical study feasibility process
clinical study
evolution asia
abbvie
pharma r&d
big-data opportunities
kyle holen
clinical trials in europe
cros
clinical study metrics
clinical trial data management
mark wingertzahn
glaxosmithcline
patient centricity
evolution europe
steven fruchtman
onconova therapeutics
patient records
chitra lele
drug safety
clinical study health
patient emrollment
graeme ladds
drug safety data
pharsafer
topstone research inc
clicnical trials
pharma discovery
kelley kendle
synchrogenix
evolution summit 2015
idiopathic pulmonary fibrosis
boehringer ingelheim pharmaceuticals
andreas grauer
amgen
tufts center
eisai pharmceuticals
johan luthman
gary romano
johnson and johnson
visiopharm
image analysis
drug development challenges
tufts
clinart mena
alaa assem
business development activities interview - clinar
lundbeck
interactive corporation
drugdev
sanaclis s.r.o.
conducting clinical trials in emerging markets wit
marcus evans evolution summit 2015
clinical trial efficiency should be a key focus
suvro ghosh
clinzen llc
acurian
roger smith
why quantitative comparison of patient recruitment
staffan gestrelius
capish
where marcus evans fits in our business developmen
syndax
hematology
oncology drug development
biomarkers
clinical trial standardization
primorus clinical trials
localization
biorasi
multitouch marketing
pharmaceutical development
hispanic patients
maximizing procedure
site identification
patient recruitment & retention
biomedical research
pharmabrand summit
medication administration
long-term care cxo summit
patient recruitment
forest research institute
ind
global regulatory strategy
new drug development
cta
translational medicine
non-porfits medical research foundation
disease treatment
modeling and simulation technologies
in silco to in vivo
optimized drug development
drug discovery summit
pharma marketing
chief marketing officers
cmos
pharmabrand
bayer pharmaceuticals
summit
Mehr anzeigen